Aligos Therapeutics Inc
F:5WK0
Aligos Therapeutics Inc
F:5WK0
Price:
4.94
EUR
5.44%
Market Closed
Market Cap:
€30.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aligos Therapeutics Inc
F:5WK0
|
US |
|
F
|
Fanuc Corp
F:FUC
|
JP |
|
A
|
ACADIA Pharmaceuticals Inc
SWB:DR6
|
US |
|
Greenyard NV
F:2P1
|
BE |
|
Smart Employee Benefits Inc
XTSX:SEB
|
CA |
|
Macfarlane Group PLC
LSE:MACF
|
UK |
|
C
|
Credit Agricole SA
DUS:XCA
|
FR |
|
IMCD NV
F:X6D
|
NL |
|
Siegfried Holding AG
F:SQG
|
CH |
|
D
|
Daiichi Sankyo Co Ltd
DUS:D4S
|
JP |
|
R
|
Rupert Resources Ltd
TSX:RUP
|
CA |
|
C
|
Charles Schwab Corp
SWB:SWG
|
US |
|
Takasago Thermal Engineering Co Ltd
F:Q74
|
JP |
|
Toyo Tire Corp
F:TYR
|
JP |
|
A
|
Amani Gold Ltd
XHAM:B7BA
|
AU |
|
C
|
Crown Holdings Inc
SWB:CWN
|
US |
|
C
|
Coeur Mining Inc
XBER:CDM1
|
US |
|
AIA Group Ltd
HKEX:1299
|
HK |
|
Dusk Group Ltd
F:6EA
|
AU |
|
L
|
Lenzing AG
XBER:LEN
|
AT |
|
G
|
Great Panther Mining Ltd
F:G3U
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5WK0's stock price target?
Not Available
5WK0 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Aligos Therapeutics Inc?
Projected CAGR
203%
203%
The compound annual growth rate for Revenue over the next 3 years is 203%.
